低能离子束修饰蛹虫草菌株高产虫草素

虫草素具有抗肿瘤、免疫调节、抗炎等多种功效。为了更好地开发蛹虫草资源,选择合适剂量的低能离子束注入蛹虫草,优化虫草素的提取工艺条件,采用紫外分光光度法检测注入前后菌株中虫草素的含量。结果表明:最佳注入剂量为2.60×1015ions/cm2,虫草素最佳的微波-超声波提取工艺为:乙醇浓度70%,提取功率200W,提取时间110s,料液比1:240。选育出虫草素含量较高的15株菌株,最高含量达(11.924±0.063)mg/g,比原始菌株增长了近30%。     

冬虫夏草菌丝体γ-谷氨酰转肽酶的探测和部分性质研究

本研究首次发现冬虫夏草发酵菌丝体含有较高活力的γ-谷氨酰转肽酶（简称CSGT）,并且通过硫酸铵分级沉淀、疏水层析、凝胶过滤层析、阴离子交换层析和制备电泳的提取纯化程序,将CSGT纯化了2300倍,然后对CSGT的基本酶学性质进行了研究。CSGT的稳定pH范围和温度范围分别为pH8-11和0-20℃, 当pH 9-10 、30℃并且以L-谷氨酸-对-硝基苯胺（简称GpNA）和双甘肽为底物时CSGT的活力达到最大值。几种还原剂均能激活CSGT,说明其活性中心含有巯基。Zn2+, Cu2+, Hg2+ , Mn2+ 等金属离子均强烈抑制CSGT活性,而K+, Ca2+, Mg2+ 和Na+等对CSGT活性没有影响。     

New Lineages of Elaphocordyceps Harboring in Lichen Thalli

All species of Elaphocordyceps parasitize the fungal genus Elaphomyces, except for three species growing on scarabid beetle larvae or cicada nymphs. During our study on the diversity of culturable endolichenic fungi, some Elaphocordyceps species are found widely harboring in lichen thalli. A total of 64 fungal strains belonging to Elaphocordyceps were isolated from 42 lichen samples respectively collected from 5 provinces of China and the Antarctic. Phylogenetic analysis based on ITS nrDNA shows that these endolichenic fungi are possibly heterospecific. The endophytic fungi of plant often provide benefits to their hosts. However, the endolichenic fungi may be parasites or nutrient competitors of the mycobiont, because they have to obtain nutrient components from mycobionts or photobionts. Our study partly proves this hypothesis, since most known species of Elaphocordyceps are parasites of fungi.     

高速逆流色谱分离制备蛹虫草中虫草素和N6-(2-羟乙基)-腺苷

采用高速逆流色谱（HSCCC）技术从蛹虫草子实体粗提物中分离制备高纯度虫草素和N⁶-(2-羟乙基)-腺苷。利用高效液相色谱（HPLC）测定目标产物在溶剂体系中的分配系数,优化HSCCC分离虫草素和N⁶-(2-羟乙基)-腺苷的溶剂体系,确定了以乙酸乙酯-正丁醇-1.5%氨水（1:4:5,V/V/V）为HSCCC的两相溶剂体系,并运用此溶剂体系,上相为固定相,下相为流动相,主机转速850r/min,流动相流速为1.5mL/min,检测波长为254nm条件下进行分离制备,在250min内从200mg蛹虫草子实体粗提物中一步分离得到10.8mg纯度99%的虫草素和6.1mg 纯度98%的N⁶-(2-羟乙基)-腺苷。该方法简便、快速,为虫草素和N⁶-(2-羟乙基)-腺苷的大量制备建立了基础。     

一株虫草头孢菌深层培养条件的研究

采用摇瓶培养的方法,以菌丝体收率为指标,通过单因子实验和正交实验确定了虫草头孢菌最佳培养条件和最佳发酵培养基配方。在相同条件下,优化培养基比原培养基的菌丝体收率提高了31.75%。     

中国拟青霉新种及其与虫草的关系

从虫草[Cordyceps sinenisis(Berk.),Sacc.]上分离到中国拟青霉新种(Paecilomyces isnenisisp.nov.),对它进行了培养和形态学研究。中国拟青霉与蛹草[cordyceps militaris(L·)Liak]的无性阶段形态非常类似,但在分生孢子形态,分生孢子和瓶梗的量度上有所不同,且两者的寄主及生境不同,故定为新种。不仅可从长子座的殭虫获得其纯培养物,也可从不长子座而长孢梗束的虫草纯化培养获得。纯培养物的形态和天然虫体的孢梗束完全相同,故认为它可能是虫草的无性阶段。     

The Disintegration of Soybean by a Cellulase Preparation from Irpex lacteus Fr. and the Enzyme Relating to It

It was found that there was a fairly well correlation between the soybean disintegrating activity (SD activity) of Driselase, a cellulase preparation from Irpex lacteus, and the improvement of feed efficiency caused from its supplementation to a ration.

When the seed coat of soybean was hydrolysed by Driselase, arabinose, galactose, and other aldoses were liberated; on the other hand, some ketoses such as fructose, sucrose, raffinose and such were detected as a result of the hydrolysis of the cotyledon. On the fractionation of Driselase with column chromatography, acid proteinase was appeared to be parallel, in a certain extent, with SD activity. These suggested that Driselase partially attacked the cell walls of the cotyledon and led to the leakage of intracellular substances such as ketoses and protein.

Since it was revealed, however, that only a kind of pectin hydrolase was detected in the fraction with high SD activity, the maceration of soybean by a pectin hydrolase was thought to be chiefly concerned with SD activity.     

冬虫夏草(Cordyceps sinensis)菌丝体固体发酵粉化学成分的分析

本研究对一种冬虫夏草(Cordyceps sinensis)菌丝体固体发酵粉的化学成份进行了分析,包括粗成份,生物活性成份,脂肪酸,氨基酸,金属元素等。冬虫夏草菌丝体固体发酵粉中3’-脱氧腺苷含量40．81μg/g,腺苷含量745．4μg/g;甘露醇的含量为165．8mg／g,多糖含量为157．3mg／g;谷氨酸,天门冬氨酸,苯丙氨酸是三大类主要氨基酸;不饱和脂肪酸是优势脂肪酸,以亚油酸,油酸为主。和文献记录的结果相比,虫草发酵粉中3’-脱氧腺苷,甘露醇的含量明显高于冬虫夏草子实体中相应成份的含量;各种氨基酸的含量和水平与冬虫夏草子实体中相应氨基酸的含量和水平相当;虫草发酵粉中的其它化学成份和冬虫夏草子实体中相应成份基本一致。     

蛹虫草几个问题的最新研究进展

蛹虫草由于具有多种生理活性功能, 在医疗保健及食品开发中具有很好的经济价值。本文重点评述了蛹虫草研发中的(1)无性型菌种的分类地位, (2)有意义的培养研究方法, (3)菌种 “退化” 与遗传变异, 和(4)生物活性物质及生理功能的新研究进展等问题。     

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris

Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although the sustained virologic response rate in the treatment of genotype 1 using new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has been improved by more than 70%, several severe side effects such as skin rash/ageusia and advanced anemia have become a problem. Under these circumstances, a new type of anti-HCV oral drug with few side effects is needed. Our recently developed HCV drug assay systems, including the HuH-7 cell line-derived OR6 and AH1R, and the Li23 cell line-derived ORL8 and ORL11, allow genome-length HCV RNAs (several strains of genotype 1b) encoding renilla luciferase to replicate efficiently. Using these systems as anti-HCV candidates, we have identified numerous existing medicines that can be used against HCV with few side effects, such as statins and teprenon. To obtain additional anti-HCV candidates, we evaluated a number of oral health supplements, and found that the capsule but not the liquid form of Cordyceps militaris (CM) (Ascomycotinanorth, North Chinese caterpillar fungus), which is used as a Chinese herbal medicine, exhibited moderate anti-HCV activity. In combination with interferon-α or ribavirin, CM exhibited an additive inhibitory effect. Among the main components of CM, cordycepin, but not ergosterol, contributed to the anti-HCV activity of CM. In consideration of all these results, we suggest that CM would be useful as an oral anti-HCV agent in combination with interferon-α and/or ribavirin.